Addressing Complex Oral Formulation Challenges Using Translational Pharmaceutics® - Cambridge, MA

Cambridge, MA, United States | 29 January 2025
Overview

Addressing Complex Oral Formulation Challenges Using Translational Pharmaceutics®

Optimizing drug delivery can be a challenging process. This is especially true for therapies that require complex formulation solutions, such as solubility enhancement or modified release technologies. These technologies require specialized expertise to succeed and are often limited by the predictive power of characterization methods.

Join us as Dr. Vanessa Zann, Executive Drug Development Consultant, leads a data-rich, deep-dive into a series of drug product optimization case studies on solubility enhancement and modified release. Each of these real-world examples will demonstrate how Translational Pharmaceutics® was applied to assist in formulation selection and optimization in an accelerated time frame, resulting in downstream success for our customers. 

Date/TimeLocation
Wednesday, January 29, 2025
11:30AM - 1:30PM
Catalyst Restaurant
300 Technology Square
Cambridge, Massachusetts, 02139
Registration: 11:30AM – Noon
Seminar with Lunch: Noon - 1:00PM
Q&A/Networking: 1:00PM – 1:30PM
*Parking is available in the Technology Garage for $10.00 which will be validated by Quotient Sciences. 
 

Space is limited! Register your interest to attend our seminar. If you have any questions or difficulty registering, reach out to [email protected].

 

*We reserve the right, at our sole discretion, to deny registration or remove any individual who is not a confirmed current or potential client/partner of Quotient Sciences.

Register
Location
Catalyst Restaurant
300 Technology Square
Cambridge, MA, United States

Meet our expert:

We look forward to meeting you at our seminar in Cambridge, MA.

Dr. Vanessa Zann

VP Scientific Consulting, TP-CP USA

Dr. Vanessa Zann is an Executive Drug Development Consultant at Quotient Sciences, with over twenty-five years industry experience...

About Vanessa

More insight from our experts:

Read More
Drug Substance, Translational Pharmaceutics, Dr. Richard Castledine Understanding the Complexity of Psychedelic Drug Development: Key Takeaways and Considerations for Drug Developers By: Dr. Richard Castledine
Read More
Get in touch
Humanity can't afford to wait, so neither can we.